EUVIMEDEUVIMED entdecken
Crossref

SELEX-discovered aptamer that inhibits cellular interleukin-17/interleukin-17 receptor interaction and antagonizes interleukin-17 signaling

Arifur Rahman Munshi, Tong Wang, Yukio Takamori, Takehiro Ando, Takumi Yokoyama, Daisuke Fuji, Zhehao Xu, Santhana Vedi, Mizuki Yamamoto, Keita Tsukamoto, Takashi Kawakami iD

Bioscience, Biotechnology, and Biochemistry · 2024

DOI: 10.1093/bbb/zbad170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2024. Verfasst von Arifur Rahman Munshi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Applied Life Science, Integrated Graduate School of Medicine, Engineering, and Agricultural Sciences, University of Yamanash…. Hauptthemen laut MEDLINE: Receptors, Interleukin-17, Interleukin-17. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: JSPS, Heiwa Nakajima Foundation, JST.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This research is based on a Systematic Evolution of Ligands by EXponential enrichment, also referred to as in vitro selection against the extracellular domain of human interleukin-17 receptor A (IL-17RA). Pull-down assay via quantitative polymerase chain reaction and chemiluminescence detection showed that the cloned RNA with the enriched sequence bound to human IL-17RA and inhibited the interaction between IL-17RA and human interleukin-17A (IL-17A). We also revealed that the newly discovered IL-17RA-binding RNA aptamer bound to cellular IL-17RA, inhibited the cellular IL-17RA/IL-17A interaction, and antagonized cellular IL-17A signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Interleukin-17Interleukin-17HumansProtein Binding

Stichwörter der Autor:innen

SELEXaptamerautoimmune diseaseinterleukin-17 receptorprotein–protein interaction inhibitor

Substanzen

Receptors, Interleukin-17Interleukin-17

Autor:innen und Institutionen

  • Department of Integrated Applied Life Science, Integrated Graduate School of Medicine, Engineering, and Agricultural Sciences, University of Yamanashi, Kofu, Yamanashi, Japan.
  • Department of Life and Environmental Sciences, Integrated Graduate School of Medicine, Engineering, and Agricultural Sciences, University of Yamanashi, Kofu, Yamanashi, Japan.
  • Faculty of Life and Environmental Sciences, Graduate Faculty of Interdisciplinary Research, University of Yamanashi, Kofu, Yamanashi, Japan.
  • JST, PRESTO, Kawaguchi, Saitama, Japan.

ORCID-Profile: Takashi Kawakami

Förderung

  • JSPS
  • Heiwa Nakajima Foundation
  • JST
  • PRESTO

Zitieren

APA

Munshi, A. R., Wang, T., Takamori, Y., Ando, T., Yokoyama, T., Fuji, D., Xu, Z., Vedi, S., Yamamoto, M., Tsukamoto, K., & Kawakami, T. (2024). SELEX-discovered aptamer that inhibits cellular interleukin-17/interleukin-17 receptor interaction and antagonizes interleukin-17 signaling. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbad170

Vancouver

Munshi AR, Wang T, Takamori Y, Ando T, Yokoyama T, Fuji D, et al. SELEX-discovered aptamer that inhibits cellular interleukin-17/interleukin-17 receptor interaction and antagonizes interleukin-17 signaling. Bioscience, Biotechnology, and Biochemistry. 2024. doi:10.1093/bbb/zbad170

BibTeX
@article{Munshi2024,
  author = {Munshi, Arifur Rahman and Wang, Tong and Takamori, Yukio and Ando, Takehiro and Yokoyama, Takumi and Fuji, Daisuke and Xu, Zhehao and Vedi, Santhana and Yamamoto, Mizuki and Tsukamoto, Keita and Kawakami, Takashi},
  title = {SELEX-discovered aptamer that inhibits cellular interleukin-17/interleukin-17 receptor interaction and antagonizes interleukin-17 signaling},
  journal = {Bioscience, Biotechnology, and Biochemistry},
  year = {2024},
  doi = {10.1093/bbb/zbad170}
}
Kostenlos starten →